Cardiovascular Systems Inc (CSII) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CSII Annual Balance Sheets →
Quarterly balance sheet trends provide context on Cardiovascular Systems Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent59.84
Marketable Securities, Current SH72.16
Cash & Short-term Investments131.00
Accounts receivable40.23
Inventories41.19
Other Current Assets0.00
Prepaid Expense And Other Assets Current8.54
Total Current Assets221.96
Equipment/Property/Plant Net30.00
Intangible Assets15.04
Other Assets, Noncurrent44.50
Total Assets311.51
Liabilities
Accounts Payable, Current AC17.09
Accrued Liabilities, Current AC19.15
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.53
Total Current Liabilities36.76
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE3.37
Other liabilities, Noncurrent11.87
Financing Obligation Long Term20.12
Total Liabilities72.12
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock682.93
Retained Earnings / Accumulated Deficit-443.41
Other Equity-0.17
Common Stockholder's Equity239.39
Total Stockholder's Equity239.39
Liabilities & Stockholder's Equity311.51
4 historic quarters locked

Sign in to unlock the full Cardiovascular Systems Inc balance sheet history.

About Cardiovascular Systems Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001180145-23-000016

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.